CM – Justin Perry of the Sloan Kettering Institute receives the New Innovator Award from the Distinguished NIH Director


From radiation therapy and clinical studies to checking in with your doctor, your care will be made as comfortable as possible.

Find out more

For the safety of our patients and employees, we are now asking all visitors to MSK to be fully vaccinated against COVID-19. Read the latest information for visitors.

Tuesday 5th October 2021

Justin Perry, PhD, cell biologist and immunologist at the Sloan Kettering Institute (SKI) by Memorial Sloan Kettering (MSK) was recognized as one of 64 recipients of the National Institutes of Health (NIH) prestigious New Innovator Award 2021. As part of the award, Dr. Perry $ 1.5 million in direct costs, split into two multi-year segments.

The Director’s New Innovator Award, launched in 2007, is part of the High-Risk, High-Reward Research program, which is highly innovative research by researchers early stage whose creativity and research have the potential to have a major impact on broad, important issues relevant to the mission of the NIH, including topics related to behavioral, social, biomedical, applied and formal sciences as well Basic, translational or clinical research.

« It’s an honor to receive an NIH Director’s Award, » said Joan Massagué, PhD, Director of SKI. « DR. Perry is an outstanding scientist and immunologist and I am confident that this will further advance his already important contributions to science. » beyond the known, « said NIH Director Francis S. Collins, MD, PhD. » These visionary researchers come from a diverse range of career levels and show that breakthrough science can emerge at any career level if the right opportunity is offered. « 

Dr. Perry is an Assistant Member of SKI, where his research focuses on understanding the rapid response circuitry that controls how a phagocyte controls excess biomass influx, immune function, and homeostasis, from Washington University in St. Louis, Missouri .

“I am very honored to have received the New Innovator Award from the NIH Director to have been, « said Dr. Perry. « It is wonderful that the NIH supports our research and relies on our work to better understand homeostatic apoptotic cell clearance. »

Manage settings


NIH,Research,NIH Director’s New Innovator Award,National Institutes of Health,NIH, Research, NIH Director’s New Innovator Award, National Institutes of Health,,,,,,,,NIH,Awards,Computer models,Neuroscience,College of Biological Sciences,,,

Donnez votre avis et abonnez-vous pour plus d’infos



[supsystic-newsletter-form id=4]

Vidéo du jour: